{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:49:26Z","timestamp":1790495366079,"version":"4.1.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1093\/jac\/dkv385","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T02:09:41Z","timestamp":1449886181000},"page":"762-774","source":"Crossref","is-referenced-by-count":16,"title":["High prevalence of PI resistance in patients failing second-line ART in Vietnam"],"prefix":"10.1093","volume":"71","author":[{"given":"Vu Phuong","family":"Thao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Minh","family":"Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tran","family":"Chinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Shikuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Van Vinh Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy E.","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"key":"2016020508432037000_71.3.762.1","unstructured":"WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection . 2013. http:\/\/apps.who.int\/iris\/bitstream\/10665\/85321\/1\/9789241505727_eng.pdf ."},{"key":"2016020508432037000_71.3.762.2","doi-asserted-by":"publisher","DOI":"10.1310\/hct09s01-1"},{"key":"2016020508432037000_71.3.762.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69155-1"},{"key":"2016020508432037000_71.3.762.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074609"},{"key":"2016020508432037000_71.3.762.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.980"},{"key":"2016020508432037000_71.3.762.6","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328351f5b2"},{"key":"2016020508432037000_71.3.762.7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830285fb"},{"key":"2016020508432037000_71.3.762.8","doi-asserted-by":"publisher","DOI":"10.1086\/380509"},{"key":"2016020508432037000_71.3.762.9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-154-7-201104050-00316","article-title":"Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1: a randomized trial","volume":"154","author":"Daar","year":"2012","journal-title":"Ann Intern Med"},{"key":"2016020508432037000_71.3.762.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032144"},{"key":"2016020508432037000_71.3.762.11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a097b"},{"key":"2016020508432037000_71.3.762.12","first-page":"769627","article-title":"Protease inhibitor resistance is uncommon in HIV-1 subtype C infected patients on failing second-line lopinavir\/r-containing antiretroviral therapy in South Africa","volume":"2011","author":"Wallis","year":"2011","journal-title":"AIDS Res Treat"},{"key":"2016020508432037000_71.3.762.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31820dc0cc"},{"key":"2016020508432037000_71.3.762.14","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0352"},{"key":"2016020508432037000_71.3.762.15","doi-asserted-by":"crossref","unstructured":"Nerrienet E , Nouhin J , Ngin S et al . HIV-1 protease inhibitors resistance profiles in patients with virological failure on LPV\/r-based 2nd line regimen in Cambodia. J AIDS Clin Res 2012; S5: 003.","DOI":"10.4172\/2155-6113.S5-003"},{"key":"2016020508432037000_71.3.762.16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir967"},{"key":"2016020508432037000_71.3.762.17","doi-asserted-by":"publisher","DOI":"10.1089\/088922203322493111"},{"key":"2016020508432037000_71.3.762.18","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2092"},{"key":"2016020508432037000_71.3.762.19","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0142"},{"key":"2016020508432037000_71.3.762.20","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2008.0193"},{"key":"2016020508432037000_71.3.762.21","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0206"},{"key":"2016020508432037000_71.3.762.22","unstructured":"UNAIDS. HIV in Asia and the Pacific . 2013. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2013_HIV-Asia-Pacific_en_0.pdf ."},{"key":"2016020508432037000_71.3.762.23","unstructured":"Vietnam Ministry of Health. HIV\/AIDS Case Report and Implementation of HIV\/AIDS Prevention and Control Programme Till September 2014. 2014. http:\/\/www.bacsisaigon.com\/tin-tuc\/tinh-hinh-dich-hiv-aids-o-viet-nam-den-het-30-9-2014-va-ket-qua-mot-so-chuong-trinh\/ ."},{"key":"2016020508432037000_71.3.762.24","unstructured":"Chi NH , Quang VM , Chinh NT . Antiretroviral therapy in HIV\/AIDS patients and the resistance of ARVs. In: Workshop on HIV\/AIDS in Vietnam\u2014Organized by Hospital for Tropical Diseases and Harvard Medical School AIDS Initiative in Vietnam . 2012."},{"key":"2016020508432037000_71.3.762.25","unstructured":"WHO. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision . 2010. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf ."},{"key":"2016020508432037000_71.3.762.26","unstructured":"Vietnam Ministry of Health. Vietnam National Guidelines for HIV\/AIDS Diagnosis and Treatment . In Vietnamese. Published with the Decision No. 3003\/QD-BYT dated 19\/08\/2009 of the Minister of Health. 2011. http:\/\/www.vaac.gov.vn\/Cms_Data\/Contents\/Vaac\/Folders\/DocumentLaw\/Vanban\/\u223ccontents\/8YUJW54X7VRF64XS\/4139-Q-BYT.pdf ."},{"key":"2016020508432037000_71.3.762.27","unstructured":"Vietnam Ministry of Health. Vietnam National Guidelines for HIV\/AIDS Diagnosis and Treatment . In Vietnamese. Published with the Decision No. 06\/2005\/QD-BYT dated 07\/03\/2005 of the Minister of Health. 2005. http:\/\/moj.gov.vn\/vbpq\/Lists\/Vn%20bn%20php%20lut\/View_Detail.aspx?ItemID=15388 ."},{"key":"2016020508432037000_71.3.762.28","unstructured":"Vietnam Ministry of Health. Vietnam National Guidelines for HIV\/AIDS Diagnosis and Treatment . In Vietnamese. 2009. http:\/\/benhnhietdoi.vn\/data\/files\/documents\/QD.3003.BYT.19.8.2009_Huong_dan_chan_doan_va_dieu_tri_HIVAIDS.pdf ."},{"key":"2016020508432037000_71.3.762.29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1545109709352884","article-title":"A simple single item rating scale to measure medication adherence: further evidence for convergent validity","volume":"8","author":"Kalichman","year":"2011","journal-title":"J Int Assoc Physicians AIDS Care"},{"key":"2016020508432037000_71.3.762.30","first-page":"642","article-title":"2014 update of the drug resistance mutations in HIV-1","volume":"22","author":"Wensing","year":"2014","journal-title":"Top Antivir Med"},{"key":"2016020508432037000_71.3.762.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2013.04.032"},{"key":"2016020508432037000_71.3.762.32","doi-asserted-by":"publisher","DOI":"10.1177\/1545109710387301"},{"key":"2016020508432037000_71.3.762.33","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181bcdac1"},{"key":"2016020508432037000_71.3.762.34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-1293.2010.00825.x","article-title":"Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline","volume":"11","author":"Hosseinipour","year":"2010","journal-title":"HIV Med"},{"key":"2016020508432037000_71.3.762.35","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1819"},{"key":"2016020508432037000_71.3.762.36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis261"},{"key":"2016020508432037000_71.3.762.37","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks310"},{"key":"2016020508432037000_71.3.762.38","doi-asserted-by":"publisher","DOI":"10.2165\/11633630-000000000-00000"},{"key":"2016020508432037000_71.3.762.39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/135965350100602S05","article-title":"Pharmacological exposure and the development of drug resistance in HIV","volume":"6","author":"Hoetelmans","year":"2001","journal-title":"Antiretrovir Ther"},{"key":"2016020508432037000_71.3.762.40","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh029"},{"key":"2016020508432037000_71.3.762.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073582"},{"key":"2016020508432037000_71.3.762.42","doi-asserted-by":"publisher","DOI":"10.1089\/088922203766774496"},{"key":"2016020508432037000_71.3.762.43","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1128\/JVI.71.9.6662-6670.1997","article-title":"Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites","volume":"71","author":"Zhang","year":"1997","journal-title":"J Virol"},{"key":"2016020508432037000_71.3.762.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106525"},{"key":"2016020508432037000_71.3.762.45","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007161"},{"key":"2016020508432037000_71.3.762.46","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq167"},{"key":"2016020508432037000_71.3.762.47","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0302"},{"key":"2016020508432037000_71.3.762.48","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833677ac"},{"key":"2016020508432037000_71.3.762.49","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4680-4686.2004"},{"key":"2016020508432037000_71.3.762.50","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0037"},{"key":"2016020508432037000_71.3.762.51","doi-asserted-by":"publisher","DOI":"10.1177\/1545109706294288"},{"key":"2016020508432037000_71.3.762.52","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.7448\/IAS.17.4.19740","article-title":"Rilpivirine versus etravirine validity in NNRTI-based treatment failure in Thailand","volume":"17","author":"Teeranaipong","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2016020508432037000_71.3.762.53","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0107"},{"key":"2016020508432037000_71.3.762.54","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1906"},{"key":"2016020508432037000_71.3.762.55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00096-10"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/3\/762\/6992430\/dkv385.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:32:18Z","timestamp":1718238738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,2,5]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1093\/jac\/dkv385"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv385","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}